For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Powerful conversations: Preserving cognition and fending off dementia
Powerful conversations: Preserving cognition and fending off dementia

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published online on 28 February.
Specialist GP Ngaire Kerse looks at the issue of dementia in New Zealand, then examines how conversational interactions might help
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
Dodge HH, Yu K, Wu CY, et al. Internet-based conversational engagement randomized controlled clinical trial (I-CONECT) among socially isolated adults 75+ years old with normal cognition or MCI: Topline results. Gerontologist 2023; 3 November online. doi.org/10.1093/geront/gnad147